Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Saeideh Milani"'
Autor:
Lia Farahi, Fatemeh Ghaemimanesh, Saeideh Milani, Seyed Mohsen Razavi, Reza Hadavi, Ali Ahmad Bayat, Ali Salimi, Mohammad Mehdi Akhondi, Hodjattallah Rabbani
Publikováno v:
Iranian Journal of Immunology, Vol 16, Iss 2, Pp 127-141 (2019)
Background: We have previously reported the aberrant expression of Fibromodulin (FMOD) in patients with chronic lymphocytic leukemia (CLL). Although FMOD has been considered as a cytoplasmic or secretory protein, we discovered the cell surface expres
Externí odkaz:
https://doaj.org/article/feaa4acd5bce439ba9d235821dd7808e
Publikováno v:
Brazilian Archives of Biology and Technology, Vol 59, Iss 0 (2016)
Cervical cancer is the second common cause of cancer deaths in women worldwide. Radioresistancy of cancer is a principal cause of treatment impairing. Inhibitor of apoptosis proteins (IAPs) widely block apoptosis against apoptotic stimuli, including
Externí odkaz:
https://doaj.org/article/32d879046e91433d9995efd42d6a4e68
Autor:
Saeideh Milani, Fatemeh Yari
Publikováno v:
Iranian Journal of Pediatric Hematology & Oncology.
Background: Microparticles (MPs) are small vesicles released from the cell membrane. Accordingly, these contain active molecules to mediate biological processes, including cell proliferation and cell cycle progression. The fusion of myeloma cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ad043b4a59aeaef6d0fa31c284fddc2
https://doi.org/10.18502/ijpho.v12i2.9074
https://doi.org/10.18502/ijpho.v12i2.9074
Autor:
Miganoosh, Simonian, Mozhan, Haji Ghaffari, Ali, Salimi, Ebrahim, Mirzadegan, Niloufar, Sadeghi, Nasim, Ebrahimnezhad, Ghazaleh, Fazli, Ramina, Fatemi, Ali-Ahmad, Bayat, Saeideh, Milani, Babak, Negahdari, Hodjattallah, Rabbani
Publikováno v:
Avicenna Journal of Medical Biotechnology.
Background: Sortilin has an important role in various malignances and can be used as a promising target to eradicate cancer cells. Methods: In this study, the expression of sortilin in 4T1 and MDA-MB231 cell lines was evaluated by flow cytometry and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba91a9bfade15c962705c7e3227a1e5a
https://doi.org/10.18502/ajmb.v14i1.8168
https://doi.org/10.18502/ajmb.v14i1.8168
Autor:
Fatemeh Ghaemimanesh, Majid Mehravar, Saeideh Milani, Ensieh M. Poursani, Kioomars Saliminejad
Publikováno v:
Journal of Cellular Physiology. 236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48ae98e05f8f625b8e8a1e66f2cd8416
https://doi.org/10.1002/jcp.30493
https://doi.org/10.1002/jcp.30493
Autor:
Saeideh Milani, Fatemeh Ghaemimanesh, Ensieh M. Poursani, Kioomars Saliminejad, Majid Mehravar
Publikováno v:
Journal of cellular physiologyREFERENCES. 236(9)
Sortilin (also known as neurotensin receptor 3) is a multitasking protein implicated in numerous pathophysiological processes, including cancer development, cardiovascular impairment, Alzheimer-type dementia, and depression. Although the definitive r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78def285f487b893bb39e81b99022a05
https://pubmed.ncbi.nlm.nih.gov/33634506
https://pubmed.ncbi.nlm.nih.gov/33634506
Autor:
Lia, Farahi, Fatemeh, Ghaemimanesh, Saeideh, Milani, Seyed Mohsen, Razavi, Mohammad Mehdi, Akhondi, Hodjattallah, Rabbani
Publikováno v:
Avicenna Journal of Medical Biotechnology
Background: The overexpression of sortilin/neurotensin receptor 3 has previously been reported in various human solid tumors but not in hematological malignancies. Here, we report the overexpression of sortilin in leukemic cells from patients with Ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da19ef8ae799e5a8db4714209095d629
https://pubmed.ncbi.nlm.nih.gov/31908734
https://pubmed.ncbi.nlm.nih.gov/31908734
Autor:
Fatemeh Ghaemimanesh, Behrouz Alirezapour, Reza Hadavi, Saeideh Milani, Ali Salimi, Hodjattallah Rabbani, Ali Ahmad Bayat
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry. 316:267-273
Receptor tyrosine kinase Ror1 is widely expressed during embryogenesis but it is absent within most mature tissues. However, expression of Ror1 has been reported in multiple human malignancies including breast cancer. High level expression of Ror1 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e23f49d03376dc4649e584c34680e366
https://doi.org/10.1007/s10967-018-5755-y
https://doi.org/10.1007/s10967-018-5755-y
Autor:
Hodjattallah Rabbani, Azam Hemmati, Reza Hadavi, Fatemeh Ghaemimanesh, Hadi Hassannia, Saeideh Milani
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37:38-44
Receptor tyrosine kinase ROR1 has been introduced as an interesting prognostic cancer marker in histopathology. The aim of this study was to produce a polyclonal antibody (PAb) against recombinant human ROR1 protein to be used as a tool for investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c47c1721366323e33e317ffe627c772
https://doi.org/10.1089/mab.2017.0059
https://doi.org/10.1089/mab.2017.0059
Autor:
Lia, Farahi, Fatemeh, Ghaemimanesh, Saeideh, Milani, Seyed Mohsen, Razavi, Reza, Hadavi, Ali Ahmad, Bayat, Ali, Salimi, Mohammad Mehdi, Akhondi, Hodjattallah, Rabbani
Publikováno v:
Iranian journal of immunology : IJI. 16(2)
We have previously reported the aberrant expression of Fibromodulin (FMOD) in patients with chronic lymphocytic leukemia (CLL). Although FMOD has been considered as a cytoplasmic or secretory protein, we discovered the cell surface expression of FMOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28c26bbdc8bdb15f1c1176366dcee5a5
https://pubmed.ncbi.nlm.nih.gov/31182687
https://pubmed.ncbi.nlm.nih.gov/31182687